Mabtas T 100 Mg Injection
3000.0 INR/Vial
Product Details:
- Indication Non-Hodgkin s Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis
- Salt Composition Rituximab 100mg
- Origin INDIA
- Dosage Form Injection
- Feature Other
- Application Other
- Ph Level 7.0 to 7.5
- Click to View more
X
Mabtas T 100 Mg Injection Price And Quantity
- 3000.0 INR/Vial
- 1 Vial
- 10 ml
- Glass Vial
- Polysorbate 80, Sodium chloride, Trisodium citrate, Water for injection
- Intas Pharmaceuticals Ltd.
- Single-use Vial
- Clear and particle free solution
- DCGI Approved
- Intas Pharmaceuticals Ltd.
- Must be diluted before administration; infusion reactions possible
- Compatible with 0.9% Sodium Chloride
- Intravenous Infusion
- Prescription Only Medicine
Mabtas T 100 Mg Injection Product Specifications
- Not enzymatic (antibody activity)
- 7.0 to 7.5
- Store at 2 C to 8 C. Do not freeze. Protect from light.
- Rituximab 100mg
- Non-Hodgkin s Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis
- 24 months Months
- Other
- Not applicable (pharmaceutical formulation, not fermentation derived) Celsius (oC)
- INDIA
- Injection
- Other
- 10 ml
- Glass Vial
- Polysorbate 80, Sodium chloride, Trisodium citrate, Water for injection
- Intas Pharmaceuticals Ltd.
- Single-use Vial
- Clear and particle free solution
- DCGI Approved
- Intas Pharmaceuticals Ltd.
- Must be diluted before administration; infusion reactions possible
- Compatible with 0.9% Sodium Chloride
- Intravenous Infusion
- Prescription Only Medicine
Mabtas T 100 Mg Injection Trade Information
- 100 Vial Per Month
- 7 Days
Product Description
Product introduction
Mabtas T 100mg Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.
Mabtas T 100mg Injection is given as an injection under the supervision of doctor. You must take it in a dose as advised by the doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include headache, weakness, edema, infection, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with hepatitis B.
Before taking it, tell your doctor if you have heart disease, liver, or planning surgery or vaccination or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Targeted Monoclonal Antibody Therapy
Mabtas T 100 mg Injection features rituximab, a chimeric monoclonal antibody that specifically targets the CD20 antigen on B-cells. This approach helps manage various cancers and autoimmune conditions by reducing abnormal cell populations and modulating immune responses. The precise mechanism of action provides improved clinical outcomes in eligible patients.
Safe and Effective Administration Guidelines
Administered intravenously, Mabtas T must be diluted with 0.9% sodium chloride before infusion. Healthcare professionals should observe patients for possible infusion reactions and adjust the process as needed. Ensuring compatibility and proper dilution safeguards patient safety and preserves product efficacy throughout the treatment cycle.
Stringent Quality and Patient Safety Standards
Manufactured by Intas Pharmaceuticals Ltd., Mabtas T complies with DCGI standards and is distributed in glass vials for optimal stability. The product remains effective for 24 months when stored within the prescribed temperature range. Clear guidance on handling and storage reinforces its safety profile and therapeutic reliability.
FAQ's of Mabtas T 100 Mg Injection:
Q: How should Mabtas T 100 mg Injection be administered?
A: Mabtas T 100 mg Injection must be diluted with 0.9% sodium chloride and administered as an intravenous infusion by a healthcare professional in a clinical setting to ensure patient safety and optimal effectiveness.Q: What conditions can Mabtas T 100 mg Injection be used to treat?
A: This injection is prescribed for the treatment of Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis, functioning as targeted immunotherapy or cancer therapy.Q: When should the injection be given, and how often is it prescribed?
A: Dosage schedule and timing depend on the specific indication and the patient's response as determined by a physician. Mabtas T should only be used under a doctor's prescription, following a tailored treatment protocol.Q: Where should Mabtas T 100 mg Injection be stored before use?
A: The injection should be stored in its original glass vial at 2C to 8C, protected from light, and must not be frozen to maintain its safety and potency.Q: What precautions are necessary during the preparation and infusion process?
A: It is crucial to dilute the solution before infusion, monitor patients for potential infusion-related reactions, and use proper aseptic techniques to ensure compatibility and minimize risks.Q: What are the main benefits of Mabtas T 100 mg Injection for patients?
A: By specifically targeting the CD20 antigen, Mabtas T helps disrupt disease processes in certain cancers and autoimmune disorders, potentially improving treatment outcomes and quality of life for patients.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Injection' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
